Herpes simplex virus as a model vector system for gene therapy in renal disease

Betsy Herold, Daniel Marcellino, Glendie Marcelin, Patricia Wilson, Christopher Burrow, Lisa M. Satlin

Research output: Contribution to journalArticle

Abstract

The past decade has been marked by significant advances in the application of gene transfer into living cells of animals and humans. These approaches have been tested in a few animal models of inherited and acquired renal diseases, including carbonic anhydrase II deficiency and experimental glomerulonephritis. Gene transfer into proximal tubular cells has been successfully accomplished by intrarenal arterial infusion of a liposomal complex or an adenoviral vector. Tubular cells from the papilla and medulla have been selectively transduced by retrograde infusion into the pelvicalyceal system of an adenoviral vector containing a reporter for β-galactosidase. Although the results of these initial studies are promising, further studies to optimize viral vectors, maximize gene delivery, minimize side-effects, and develop cell-specific and long-term regulated gene expression are critical to the success of gene therapy targeted to specific compartments of the kidney. Our recent efforts have focused on defining the cellular pathways responsible for viral entry and infection into renal epithelial cells using herpes simplex virus (HSV) as a model vector. We anticipate that a solid understanding of the basic scientific principles underlying viral entry and gene expression into specific populations of renal cells will facilitate the design of successful therapeutic viral-based gene transfer strategies.

Original languageEnglish (US)
JournalKidney International
Volume61
Issue numberSUPPL. 1
StatePublished - 2002
Externally publishedYes

Fingerprint

Simplexvirus
Genetic Therapy
Kidney
Viral Genes
Galactosidases
Genes
Gene Expression
Virus Diseases
Glomerulonephritis
Animal Models
Epithelial Cells
Population

Keywords

  • Gene transfer
  • Herpes simplex
  • Viral vectors

ASJC Scopus subject areas

  • Nephrology

Cite this

Herold, B., Marcellino, D., Marcelin, G., Wilson, P., Burrow, C., & Satlin, L. M. (2002). Herpes simplex virus as a model vector system for gene therapy in renal disease. Kidney International, 61(SUPPL. 1).

Herpes simplex virus as a model vector system for gene therapy in renal disease. / Herold, Betsy; Marcellino, Daniel; Marcelin, Glendie; Wilson, Patricia; Burrow, Christopher; Satlin, Lisa M.

In: Kidney International, Vol. 61, No. SUPPL. 1, 2002.

Research output: Contribution to journalArticle

Herold, B, Marcellino, D, Marcelin, G, Wilson, P, Burrow, C & Satlin, LM 2002, 'Herpes simplex virus as a model vector system for gene therapy in renal disease', Kidney International, vol. 61, no. SUPPL. 1.
Herold B, Marcellino D, Marcelin G, Wilson P, Burrow C, Satlin LM. Herpes simplex virus as a model vector system for gene therapy in renal disease. Kidney International. 2002;61(SUPPL. 1).
Herold, Betsy ; Marcellino, Daniel ; Marcelin, Glendie ; Wilson, Patricia ; Burrow, Christopher ; Satlin, Lisa M. / Herpes simplex virus as a model vector system for gene therapy in renal disease. In: Kidney International. 2002 ; Vol. 61, No. SUPPL. 1.
@article{68c33ca0e61344f287125d33753b27c4,
title = "Herpes simplex virus as a model vector system for gene therapy in renal disease",
abstract = "The past decade has been marked by significant advances in the application of gene transfer into living cells of animals and humans. These approaches have been tested in a few animal models of inherited and acquired renal diseases, including carbonic anhydrase II deficiency and experimental glomerulonephritis. Gene transfer into proximal tubular cells has been successfully accomplished by intrarenal arterial infusion of a liposomal complex or an adenoviral vector. Tubular cells from the papilla and medulla have been selectively transduced by retrograde infusion into the pelvicalyceal system of an adenoviral vector containing a reporter for β-galactosidase. Although the results of these initial studies are promising, further studies to optimize viral vectors, maximize gene delivery, minimize side-effects, and develop cell-specific and long-term regulated gene expression are critical to the success of gene therapy targeted to specific compartments of the kidney. Our recent efforts have focused on defining the cellular pathways responsible for viral entry and infection into renal epithelial cells using herpes simplex virus (HSV) as a model vector. We anticipate that a solid understanding of the basic scientific principles underlying viral entry and gene expression into specific populations of renal cells will facilitate the design of successful therapeutic viral-based gene transfer strategies.",
keywords = "Gene transfer, Herpes simplex, Viral vectors",
author = "Betsy Herold and Daniel Marcellino and Glendie Marcelin and Patricia Wilson and Christopher Burrow and Satlin, {Lisa M.}",
year = "2002",
language = "English (US)",
volume = "61",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Herpes simplex virus as a model vector system for gene therapy in renal disease

AU - Herold, Betsy

AU - Marcellino, Daniel

AU - Marcelin, Glendie

AU - Wilson, Patricia

AU - Burrow, Christopher

AU - Satlin, Lisa M.

PY - 2002

Y1 - 2002

N2 - The past decade has been marked by significant advances in the application of gene transfer into living cells of animals and humans. These approaches have been tested in a few animal models of inherited and acquired renal diseases, including carbonic anhydrase II deficiency and experimental glomerulonephritis. Gene transfer into proximal tubular cells has been successfully accomplished by intrarenal arterial infusion of a liposomal complex or an adenoviral vector. Tubular cells from the papilla and medulla have been selectively transduced by retrograde infusion into the pelvicalyceal system of an adenoviral vector containing a reporter for β-galactosidase. Although the results of these initial studies are promising, further studies to optimize viral vectors, maximize gene delivery, minimize side-effects, and develop cell-specific and long-term regulated gene expression are critical to the success of gene therapy targeted to specific compartments of the kidney. Our recent efforts have focused on defining the cellular pathways responsible for viral entry and infection into renal epithelial cells using herpes simplex virus (HSV) as a model vector. We anticipate that a solid understanding of the basic scientific principles underlying viral entry and gene expression into specific populations of renal cells will facilitate the design of successful therapeutic viral-based gene transfer strategies.

AB - The past decade has been marked by significant advances in the application of gene transfer into living cells of animals and humans. These approaches have been tested in a few animal models of inherited and acquired renal diseases, including carbonic anhydrase II deficiency and experimental glomerulonephritis. Gene transfer into proximal tubular cells has been successfully accomplished by intrarenal arterial infusion of a liposomal complex or an adenoviral vector. Tubular cells from the papilla and medulla have been selectively transduced by retrograde infusion into the pelvicalyceal system of an adenoviral vector containing a reporter for β-galactosidase. Although the results of these initial studies are promising, further studies to optimize viral vectors, maximize gene delivery, minimize side-effects, and develop cell-specific and long-term regulated gene expression are critical to the success of gene therapy targeted to specific compartments of the kidney. Our recent efforts have focused on defining the cellular pathways responsible for viral entry and infection into renal epithelial cells using herpes simplex virus (HSV) as a model vector. We anticipate that a solid understanding of the basic scientific principles underlying viral entry and gene expression into specific populations of renal cells will facilitate the design of successful therapeutic viral-based gene transfer strategies.

KW - Gene transfer

KW - Herpes simplex

KW - Viral vectors

UR - http://www.scopus.com/inward/record.url?scp=0036175393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036175393&partnerID=8YFLogxK

M3 - Article

VL - 61

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - SUPPL. 1

ER -